Impact of Neurochecks on Sleep in Critically Ill Adults

Sponsor
University of California, San Diego (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05864300
Collaborator
(none)
22
1
2
11
2

Study Details

Study Description

Brief Summary

Background: Following acute brain injury (ABI), patients are monitored in the intensive care unit (ICU) where providers rely on frequent neurological examinations ("neurochecks") to assess for neurodeterioration. Serial neurochecks are part of guideline recommendations, but there is equipoise between hourly (Q1) and every-other-hour (Q2) evaluation. In the ICU, care-related awakenings occur frequently, but it is unclear if differential neurocheck frequencies result in differential sleep, providing the scientific premise for this proposal.

Population: Twenty-two patients (N=11 per group) who have undergone elective aneurysm coiling will be enrolled. On post-operative day (POD) 0, patients will be screened and approached for informed consent if they do not meet exclusion criteria, e.g., prior intracranial injury, sleep disorders, cognitive impairment, mechanical ventilation. Patients with elective aneurysm coiling are being chosen because they require ICU level of care following their intracranial procedure, but do not have structural brain injury or ongoing sedation needs that might impact sleep measurements.

Methods: Usual care: Patients are monitored every 15-30 minutes for up to 6 hours post-procedure, then Q1 or Q2 for up to 24 hours. If these patients remain stable, they are discharged home on post-operative day (POD) 1. Proposed Intervention: Enrolled patients will be randomized to Q1 or Q2 neurochecks following the institutionally required 6 hours of stable neurological and vascular checks. Once randomized, patients will undergo placement of electroencephalogram (EEG) with video, electrooculogram, and chin lead. The video EEG will be in place for at least 8 hours to include the overnight (10PM-6AM) time period. Following completion of the recording, the signals obtained will be reviewed by a blinded polysomnographic sleep technician for sleep characteristics including quantitative assessments of wakefulness, deep (N3) sleep, REM sleep, sleep efficiency, and sleep fragmentation and arousals. On POD1, patients and their nurse will fill out the Richards-Campbell Sleep Questionnaire to rate subjective sleep quality.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Neurocheck frequency
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Impact of Neurochecks on Sleep in Critically Ill Adults
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hourly Neurochecks

Patients awakened for neurological exams every hour

Behavioral: Neurocheck frequency
Randomized to hourly or every-other-hour examinations

Active Comparator: Every-Other-Hour Neurochecks

Patients awakened for neurological exams every-other-hour

Behavioral: Neurocheck frequency
Randomized to hourly or every-other-hour examinations

Outcome Measures

Primary Outcome Measures

  1. Sleep efficiency [Within 24 hours of enrollment]

    Ratio of total sleep time compared to time in bed, reported as a percentage

Secondary Outcome Measures

  1. Wakefulness [Within 24 hour of enrollment]

    Blinded quantitative assessment of time spent awake

  2. REM Sleep [Within 24 hour of enrollment]

    Blinded quantitative assessment of time spent in REM sleep

  3. Deep Sleep [Within 24 hour of enrollment]

    Blinded quantitative assessment of time spent in deep sleep

  4. Arousals [Within 24 hour of enrollment]

    Blinded quantitative assessment of number of arousals (as defined by American Academy of Sleep Medicine)

  5. Sleep quality (subjective) [Within 24 hour of enrollment]

    As measured by Richards Campbell Sleep Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adult patients age >18 years who are status post uncomplicated elective coiling of unruptured cerebral aneurysm.
Exclusion Criteria:
  1. Patients with past or current intracranial injury or disease.

  2. Patients with known flow-limiting pathology of carotid arteries, vertebral arteries, or intracranial arteries.

  3. Incomplete resolution of aneurysm.

  4. Known sleep disorders (e.g., insomnia)

  5. Pregnancy.

  6. Incarceration.

  7. Inability to communicate in English

  8. Cognitive impairment or lack of decision-making capacity.

  9. Ongoing sedation.

  10. Mechanical ventilation

Contacts and Locations

Locations

Site City State Country Postal Code
1 UC San Diego Health San Diego California United States 92130

Sponsors and Collaborators

  • University of California, San Diego

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jamie Labuzetta, Clinical Professor of Neurosciences, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT05864300
Other Study ID Numbers:
  • UCSD IRB: #806351
First Posted:
May 18, 2023
Last Update Posted:
May 23, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jamie Labuzetta, Clinical Professor of Neurosciences, University of California, San Diego
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2023